The role of B cell as antigen-presenting cell (APC) for CD4 + T cell response is not well defined. Reports suggest that B cells are involved in the tolerance response to self-antigens derived from the anterior chamber of the eye [1] [2] [3] and thymus 4-6 as well as foreign antigens from the mucosal route 7-9 . Adoptive transfer of B cells prevented the T cell-induced inflammatory bowel disease and also the chemical-induced colitis [9] [10] [11] . The antigen-presenting B cells induced antigen-specific CD4 + T cells proliferation in vivo and exhibited a decreased proliferative response to antigen ex vivo with a controversial observation of forkhead box P3 (Foxp3) 
The role of B cell as antigen-presenting cell (APC) for CD4 + T cell response is not well defined. Reports suggest that B cells are involved in the tolerance response to self-antigens derived from the anterior chamber of the eye [1] [2] [3] and thymus [4] [5] [6] as well as foreign antigens from the mucosal route [7] [8] [9] . Adoptive transfer of B cells prevented the T cell-induced inflammatory bowel disease and also the chemical-induced colitis [9] [10] [11] . The antigen-presenting B cells induced antigen-specific CD4 + T cells proliferation in vivo and exhibited a decreased proliferative response to antigen ex vivo with a controversial observation of forkhead box P3 (Foxp3) expression 12, 13 . Furthermore, in vitro naïve B cells had an ability to convert naïve CD4 + T cells into Foxp3 − CD62L hi CD25 + Treg cells without additional cytokines through mature immunological synapses but not by bone marrow-derived dendritic cells 14 . Other studies showed that B cells enhanced the induction of Foxp3 + Treg cells in the presence of transforming growth factor (TGF)-β and interleukin (IL)-2 15 and B cells preferentially induced Foxp3 + Treg cells proliferation in an antigen-specific manner 16 . These studies highlight the role of B cells in the induction of tolerance of CD4 + T cells although the underlying mechanisms remain unclear.
The most well-known inducible Foxp3 − Treg cells is type 1 regulatory (Tr1) cells that can be induced by additional IL-10 17, 18 or IL-27 [19] [20] [21] in the culture. By microarray analysis, IL-10-induced human Tr1 cell clone expressed CD49b, LAG3, and CD226 and similar expression pattern also observed in murine IL-10-producing T cells 18 . Another in vivo study demonstrated that IL-10-producing CD4 + T cells expressed higher levels of c-Maf and IL-21 after intranasal anti-CD3ε antibody treatment and these expressions also observed on the IL-27-driven Tr1 cells in vitro 20 . T cell activation in the presence of vitamin D3 and dexamethasone induced the IL-10-producing T cells with regulatory function but not Foxp3 expression 22, 23 . In addition to soluble factors, the inducible T-cell co-stimulator (ICOS)-ICOS ligand and glucocorticoid-induced TNFR-related (GITR)-GITR ligand pathways also reported to being critical for IL-10-producing T cells generation 19, [24] [25] [26] [27] . Our previous studies reported that splenic B cells have the potential to induce CD4
Foxp3
− Treg cells, which named as Treg-of-B cells, with suppressive function as well as the Peyer's patches B cells and peritoneal B-1a cells [28] [29] [30] [31] [32] . 
Results

Repeated stimulation of B cell-induced CD4
+ IL-10-producing Treg cells. The present study investigated the effect of B cells as APCs on naïve CD4 + CD25 − T cells without additional cytokine supplements. T cells collected at different co-culture rounds with OVA 323-339 peptide-pulsed B cells as Treg-of-B (ToB)-1, 2, and -3 (Fig. 1A) . After repeated stimulation of B cells, OVA-specific Treg-of-B3 cells enhanced anergic response and suppressive function in antigen-specific (Fig. 1B) and non-antigen-specific manners (see Supplementary Fig. S1A ). Treg-of-B3 cells also increased the frequency of IL-10-and IL-4-producing populations but decreased the frequency of interferon (IFN)-γ -producing population (Fig. 1C,D) . These results indicated that repeated stimulation of antigen-presenting B cells, without additional IL-10 or other cytokine supplements, converted CD4 +
CD25
− T cells into IL-10-producing Treg-of-B cells.
IL-10-producing Treg-of-B cells expressed c-Maf not Foxp3. Next, we analyzed the expression of transcriptional factors in Treg-of-B cells. The expression level of c-Maf increased significantly after multiple B-T co-cultures among the well-known transcriptional factors that regulated IL-10 promoter region in our microarray results (data not shown). In consistent with these, the expression of c-Maf increased in Treg-of-B3 cells compared to that of Treg-of-B1 cells in both mRNA and protein levels ( Fig. 2A-C) . Treg-of-B cells increased the expression of c-Maf after multiple co-cultures but did not alter the expression of Helios or Foxp3 as naïve CD4 + CD25 + (Treg) cells did (Fig. 2B,C) . We found that the mRNA levels of IL-10 and IL-4 elevated in Treg-of-B3 cells; furthermore, the major IL-10-and IL-4-producing Treg-of-B3 cells confined to the c-Maf-expressing populations ( Fig. 2A,D) . These results suggested that repeated stimulation of antigen-presenting B cells induced IL-10 expression in Treg-of-B cells might be via the activation of c-Maf.
Treg-of-B cells differed from the IL-10-induced Tr1 cells. The cytokine profiles of activated Treg-of-B cells were analyzed and compared to the primary purified splenic CD4 + CD25 − (T) and CD4 + CD25 + T (Treg) cells. After multiple co-cultures, Treg-of-B3 cells increased the production of IL-10 and IL-4 and decreased the production of IFN-γ and IL-2 compared to that of Treg-of-B1 cells (Fig. 3A) . The level of IL-10 elevated significantly during Treg-of-B3 induction ( + , and CD49b + populations (Fig. 3C,D) . In addition, IL-10 played a role but not the only role in the of ICOS, CTLA4, and c-Maf whereas decreased the expression level of LAG3 (Fig. 4A,B) . The suppressive assay was performed with the insertion of transwell to exclude the cell-cell contact dependent suppression. Strikingly, Treg-of-B3 cells less relied on the cell contact-dependent suppression as Treg-of-B1 did and IL-10 involved in the soluble factor-dependent suppression of Treg-of-B3 cells (Fig. 4C) . We further investigated the effect of increased expressions of CTLA4 and IL-10 of Treg-of-B3 cells compared to that of Treg-of-B1 cells. The blockade of IL-10 receptor reversed the suppression of Treg-of-B3 cells and the combination with the blockade of CTLA4 enhanced the reversion (Fig. 4D) . The similar results also demonstrated in the CFSE-labeled suppressive assay, Treg-of-B3 cells inhibited responder T cells proliferation in a CTLA4 and IL-10-dependent manner rather than LAG3 (see Supplementary Fig. S4 ). Furthermore, the present study investigated the effect of repeated stimulation of B cell in a non-antigen-specific manner in the presence of anti-CD3 and anti-CD28 monoclonal antibodies (see Supplementary Fig. S2 ). Non-antigen-specific Treg-of-B3 cells shared characteristics with antigen-specific Treg-of-B3 cells, including the expressions of ICOS, CTLA4, PD1, LAG3, c-Maf, and IL-10, and anergic phenotype as well as the suppressive activity through IL-10 and CTLA4. These results suggested that IL-10 and CTLA4 played important roles in the suppressive ability of Treg-of-B cells with multiple B-T co-cultures.
B cell-induced regulatory T cells in a contact-dependent manner. We investigated the inductive mechanism of Treg-of-B cells. The levels of IL-10, IL-27, and TGF-β increased during Treg-of-B3 cells induction ( Fig. 3B and see Supplementary Fig. S3A ). However, IL-10-derived from B cell did not play a role in the induction of suppressive Treg-of-B3 cells (see Supplementary Fig. S3B ). In consistent with these, the neutralization of IL-10 and IL-27 plus TGF-β during Treg-of-B3 cells culture period did not alter their suppressive function (see Supplementary Fig. S3C ). Then, the role of cell-cell contact during B-T co-cultures was determined by insertion of transwell. As the presence of transwell, T-of-(B) [To(B) in the figure] cells did not increase the level of IL-10 in culture circumstances (Fig. 5A ) and T-of-(B) cells did not possess anergic phenotype or suppressive function significantly (Fig. 5B) . We found that T-of-(B) cells expressed lower levels of c-Maf, CTLA4, IL-10, PD1, and OVA-specific transgenic TCR (Fig. 5C,D) . These results indicated that cell-cell contact was required for the induction of IL-10-producing Treg-of-B cells. 
IL-
Discussion
It has been known that B cells play the immunomodulatory role physiologically 34, 35 . Recent studies suggest that B cell participated in the tumor-associated regulatory immune response 36, 37 . Hitherto, we have reported the ability of B cells derived from spleen, Peyer's patches, and peritoneal cavity had the potential to induce CD4 + CD25 + Foxp3 − Treg cells in vitro [28] [29] [30] [31] [32] . Treg-of-B cells expressed CD25, ICOS, PD1, and LAG3 and this pattern conserved in strains and stimulations as well as the origin of B cells. Treg-of-B cells protected mice from Th2 cells mediated airway hyperresponsiveness, airway inflammation, and hyper-produced IgE in allergic asthma in both antigen-specific and antigen-specific fashion 28, 30, 31 . Non-antigen-specific Treg-of-B cells induced by anti-CD3 and anti-CD28 monoclonal antibodies prevented mice from osteolysis and joint inflammation in collagen-induced arthritis 32 ; furthermore, Treg-of-B cells protected mice from T-cell-induced colitis in an IL-10-independent manner 33 . In this study, we reported that Treg-of-B cells with repeated stimulation of antigen-presenting B cells increased the expression of IL-10, c-Maf, ICOS, and CTLA4 and the suppressive function through IL-10 and CTLA4. The non-antigen-specific Treg-of-B cells induced by monoclonal antibodies shared similar phenotype and the IL-10 and CTLA4-mediated regulatory activities. Furthermore, the single antigen-specific Treg-of-B cells increased their inhibitory ability in a non-antigen-dependent manner. Our data also suggested that cell-cell contact rather than IL-10 or IL-27 played the crucial role of Treg-of-B cell generation. In conclusion, these results indicated repeated stimulation of B cells induced CD4 + Foxp3 − T cells acquired suppressive ability through IL-10 and CTLA4 in the cell-cell contact dependent manner. CD4 + Foxp3 − Treg-of-B cells proliferated during B-T co-cultures but hypoproliferated during the suppressive assay. This observation was consistent with that self-antigen-bearing B cells stimulated antigen-specific T cells proliferation in vivo 13, 38 . B-cells-activated self-antigen-specific CD4 + T cells decreased proliferative capacity ex vivo 12, 39, 40 , and which unresponsiveness without association with Foxp3 expression 13 . Addition to self-antigens, genetically B cell-deficient mice had a defected tolerogenic response to antigen from the oral route or nasal route 8, 41 . In contrary to these, the frequency of intrathymic B cells correlated with thymic . Human IL-10-induced Tr1 cell clones expressed CD49b, LAG3, and CD226 18 and CD226 involved in the activation of human Tr1 cells-mediated lysis of myeloid APCs 44 . Although there was no study reported that murine Tr1 cells lysis APCs via CD226, we supposed that the CD226-mediated Tr1 cell lysis mechanism would be clearly detected in human Tr1 cell clones rather the murine enriched Tr1 cell population. Bacchetta et al. showed that the up-regulation of CTLA4 on antibodies activated human IL-10-induced Tr1 cell clones yet demonstrated that CTLA4 play a role in the suppressive function of Tr1 cells 45 . In addition to the suppressive mechanism, the induction of Treg-of-B cells did not require additional cytokine supplement that . Adoptive transfer of B cells attenuated DSS-induced colitis in an IL-10-independent manner 11 and B cells ameliorated T-cell-mediated inflammatory bowel disease by inducing Tr1 cells in an IL-27-depedent manner 10 . These findings are consistent with that previous results from our laboratory showed that IL-10-deficient B cells induced functional Treg-of-B cells and suggested IL-10 was not essential for the generation of Treg-of-B cells 29 . Indeed, the present report confirmed the dispensable role of IL-10 by IL-10-deficient B cell and neutralization of IL-10 during Treg-of-B3 cells generation. Neutralization of IL-10 and IL-27 did not alter the Treg-of-B3 cells induction, although the levels of IL-10, IL-27, and TGF-β increased during Treg-of-B3 cells induction. In conclusion, the antigen-presenting B cells induced IL-10-producing regulatory T cells might be through the activation of c-Maf by cell-cell contact.
We herein suggested that cell-cell contact was required for Treg-of-B cells generation while the transwell insertion reversed the suppressive function and expressions of IL-10, c-Maf, CTLA4, PD1, and antigen-specific TCR. Previous in vitro cell culture system demonstrated that splenic B cells required cell-cell contact including CD80 and CD86 costimulation for Treg-of-B cells induction 29 . In consistent with these, B-cell-induced T cell generated with additional anti-CD28 antibody decreased suppressive ability 53 . Some reports suggested that ICOS-ICOSL axis played a role in the induction of IL-10-producing Treg cells 24, 25, 43, 54 , and ICOS regulated the suppressive function of Treg cells 43, 55, 56 . Other studies showed that PD1 played a major role in the down-regulation of TCR signaling 57 , and PD1-PD ligands involved in the induction of peripheral tolerance [58] [59] [60] . These suggested that several pathways might involve in the fine-tuned generation mechanism of Treg-of-B cells.
In conclusion, the present study showed that repeated stimulation of B cells increased the expressions of IL-10, c-Maf, ICOS, and CTLA4 of Treg-of-B cells in an IL-10 and IL-27-independent and cell-cell contact dependent manner. Furthermore, antigen-specific Treg-of-B cells exerted IL-10 and CTLA4-dependent suppressive functions in both antigen-specific and non-antigen-specific fashion. We expect our findings might further explore the feasibility of application of manipulated B cells for tolerance and anti-tumor responses. 
Preparation of Treg-of-B cells. Splenic B220
+ and CD4 + CD25 − cells were purified by immunomagnetic selection using magnetic nanoparticles conjugated antibodies (anti-Mouse CD45RB/B220 Magnetic Particles, BD Biosciences, San Jose, CA, USA; EasySep Mouse CD4 + T cell isolation kit, STEMCELL, Canada). Positive or negative selections were performed to purify each cell population according to the manufacturer's instructions. The purity of the cells was confirmed by flow cytometry and was at least 95%.
As showed in Fig. 1A , naïve DO11.10 CD4 + CD25 − cells were cultured with OVA 323-339 peptide-pulsed BALB/c B220 + cells at a ratio of 1:1. After 3 days, half of medium were replaced with fresh medium and supplemented recombinant IL-2 (final concentration to 100 U mL CTG C; Il4, TGT CAT CCT GCT CTT CTT TCT C and TCT GTG GTG TTC TTC GTT GC; gapdh, GAT GGG TGT GAA CCA CGA GA and AGA TCC ACG ACG GAC ACA T.
Flow cytometry. Flow cytometry was performed according to standard procedures. Data acquisition was performed on a FACSCalibur (BD), and data were analyzed using the CellQuest Pro software (BD).
The following listed fluorescent-labeled anti-mouse monoclonal antibodies (and clone names) all purchased from eBioscience (San Diego, CA): B220 (RA3-6B2), CD4 (GK1.5), DO11.10 TCR (KJ1-26), CD25 (PC61. Statistical analysis. Statistical analysis was performed with Mann-Whitney test or one-way ANOVA, where appropriate, by using GraphPad Prism v.5.0 Software (GraphPad, San Diego, CA). A p-value < 0.05 was considered as statistical significance. *p < .05; **, p < .01; ***p < .001. All data expressed as mean ± SD.
